WeVote
Log In

Bill

Bill

HB 2253

Relating to pharmacy benefit managers.

2025 Regular Session Introduced by Kim Wallan

HB 2253 regulates Oregon pharmacy benefit managers' operations to address drug pricing and medication access impacts on patients and pharmacies.

In committee upon adjournment.
0
WeVote Research Nonpartisan
Bill Summary · HB 2253

Legislative bill overview

HB 2253 addresses the regulation of pharmacy benefit managers (PBMs) in Oregon. While specific provisions aren't detailed in the available information, the bill's referral to the Behavioral Health and Health Care Committee suggests it targets PBM practices affecting medication access, pricing, or pharmacy operations.

Why is this important

PBMs act as intermediaries between insurers, pharmacies, and patients, controlling which medications are covered and at what cost. Their practices significantly impact drug affordability and pharmacy viability, making regulation a consequential policy issue affecting healthcare costs for Oregon residents and the sustainability of community pharmacies.

Potential points of contention

  • PBM pricing power: Stakeholders disagree on whether PBMs should face restrictions on negotiating rebates, formulary exclusions, or price-setting practices that critics say inflate costs
  • Pharmacy independence vs. efficiency: Independent pharmacies may support stricter PBM oversight, while insurers argue current practices control costs and ensure medication access
  • Market competition concerns: Opponents may argue regulation could reduce PBM leverage to negotiate lower drug prices, while supporters contend consolidation gives PBMs excessive market power

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.